Inventor · disambiguated record
Natasha Levenkova
Also filed as: LEVENKOVA NATASHA
4 granted patents·6 pending applications·3 citations·filing 2013–2025
62Inventor score
Files withREGENERON PHARMA10
Top patents by PatentIndex Score
10 records- 0188US10820582B2Non-human animals having an engineered immunoglobulin Λ light chain locusREGENERON PHARMA·Filed 2017·Granted Nov 3, 2020·3 cites·21 claims
- 0282US2024156070A1Common light chain mouseREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0373US2025386808A1Non-human animals expressing exogenous terminal deoxynucleotidyltransferaseREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0471US12295354B2Non-human animals expressing exogenous terminal deoxynucleotidyltransferaseREGENERON PHARMA·Filed 2021·Granted May 13, 2025·0 cites·19 claims
- 0568US12433264B2Non-human animals having an engineered immunoglobulin lambda light chain locusREGENERON PHARMA·Filed 2020·Granted Oct 7, 2025·0 cites·21 claims
- 0667US2019090462A1Common light chain mouseREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 0767US2019021295A1Common light chain mouseREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 0863US10980221B2Non-human animals expressing exogenous terminal deoxynucleotidyltransferaseREGENERON PHARMA·Filed 2017·Granted Apr 20, 2021·0 cites·21 claims
- 0961US2022090060A1Identification and production of antigen-specific antibodiesREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1059US2013185821A1Common Light Chain MouseREGENERON PHARMA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Natasha Levenkova files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →